Roche agrees for Sanofi to be responsible for the OTC marketing and distribution of Tamiflu in the US market, as it works on approval for its Xofluza competitor product.
InvVax’s universal flu vaccine candidate has demonstrated preclinical success as the company prepares for a Phase I clinical trial, supported by a Series A fundraising round.
Roche has asked Tamiflu distributors to prioritize US regions hardest hit by flu as it works to address packaging delays expected to limit supplies of the oral suspension version of the antiviral for the rest of the month.
A statin-based drug candidate is being touted as a potential rival
to Roche's flu vaccine Tamiflu (oseltamivir phosphate) after its
developers revealed yesterday that it showed "superiority"
in the preclinic.
US drug heavyweight Pfizer is pushing through into the increasingly
profitable vaccine market with the purchase of privately held UK
firm PowderMed for an undisclosed sum.
As worldwide fears of a bird flu pandemic escalates, US border control are fighting an influx of fake Tamiflu products being imported into the country. Such products have been surfacing across the country as the global Tamiflu shortage has led to a scramble...
Pall Corporation has revealed a unique approach for speeding
vaccine production, which could provide a solution to the
potentially huge demand for vaccines by governments and
pharmaceutical manufacturers in response to the avian flu...